The Lancet Diabetes and Endocrinology
Fattore di Impatto - Analisi · Trend · Previsione · Ranking
Fattore di Impatto
2019-2020
25.34
Trend del Fattore di Impatto
Riviste Accademiche Correlate
Riviste Accademiche Popolari
The Lancet Diabetes and Endocrinology Fator de Impacto
Il Fattore di Impatto 2019-2020 di The Lancet Diabetes and Endocrinology è 25.34, appena aggiornato nel 2020.
The Lancet Diabetes and Endocrinology - Journal Impact IF
The 2019-2020 Journal Impact IF of The Lancet Diabetes and Endocrinology is 25.34, which is just updated in 2020.
The highest Fattore di Impatto of The Lancet Diabetes and Endocrinology is 25.34.
The lowest Fattore di Impatto of The Lancet Diabetes and Endocrinology is 9.185.
The total growth rate of The Lancet Diabetes and Endocrinology IF is 175.9%.
The annual growth rate of The Lancet Diabetes and Endocrinology IF is 29.3%.
Classifica dei Fattori di Impatto
| Sottocategoria | Quartile | Rango | Percentuale |
|---|---|---|---|
| Internal Medicine | Q1 | 1/128 |
Internal Medicine 99% |
| Endocrinology, Diabetes and Metabolism | Q1 | 1/217 |
Endocrinology, Diabetes and Metabolism 99% |
| Endocrinology | Q1 | 1/118 |
Endocrinology 99% |
· In the Internal Medicine research field, the Quartile of The Lancet Diabetes and Endocrinology is Q1. The Lancet Diabetes and Endocrinology has been ranked #1 over 128 related journals in the Internal Medicine research category. The ranking percentile of The Lancet Diabetes and Endocrinology is around 99% in the field of Internal Medicine.
The Lancet Diabetes and Endocrinology Key Factor Analysis
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of The Lancet Diabetes and Endocrinology is Q1. The Lancet Diabetes and Endocrinology has been ranked #1 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of The Lancet Diabetes and Endocrinology is around 99% in the field of Endocrinology, Diabetes and Metabolism.
The Lancet Diabetes and Endocrinology Key Factor Analysis
· In the Endocrinology research field, the Quartile of The Lancet Diabetes and Endocrinology is Q1. The Lancet Diabetes and Endocrinology has been ranked #1 over 118 related journals in the Endocrinology research category. The ranking percentile of The Lancet Diabetes and Endocrinology is around 99% in the field of Endocrinology.
The Lancet Diabetes and Endocrinology Key Factor Analysis
Trend di Collaborazione Internazionale
Tendenza Documenti Citati
Storia del Fattore di Impatto
| Anno | Fattore di Impatto |
|---|---|
| Anno | Fattore di Impatto |
| 2019-2020 | 25.34 |
| 2018-2019 | 24.54 |
| 2017-2018 | 19.313 |
| 2016-2017 | 19.742 |
| 2015-2016 | 16.32 |
| 2014-2015 | 9.185 |
| 2013-2014 | - |
| 2012-2013 | - |
| 2011-2012 | - |
· The 2019-2020 Fattore di Impatto of The Lancet Diabetes and Endocrinology is 25.34
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2018-2019 Fattore di Impatto of The Lancet Diabetes and Endocrinology is 24.54
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2017-2018 Fattore di Impatto of The Lancet Diabetes and Endocrinology is 19.313
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2016-2017 Fattore di Impatto of The Lancet Diabetes and Endocrinology is 19.742
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2015-2016 Fattore di Impatto of The Lancet Diabetes and Endocrinology is 16.32
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2014-2015 Fattore di Impatto of The Lancet Diabetes and Endocrinology is 9.185
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Fattore di Impatto 2013-2014 of The Lancet Diabetes and Endocrinology is still under analysis. Stay Tuned!
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Fattore di Impatto 2012-2013 of The Lancet Diabetes and Endocrinology is still under analysis. Stay Tuned!
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Fattore di Impatto 2011-2012 of The Lancet Diabetes and Endocrinology is still under analysis. Stay Tuned!
The Lancet Diabetes and Endocrinology Key Factor Analysis
Introduzione
Each monthly issue of The Lancet Diabetes & Endocrinology features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally. The journal publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.
The ISSN of The Lancet Diabetes and Endocrinology is
2213-8587
.
An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The ISSN (Online) of The Lancet Diabetes and Endocrinology is
2213-8595
.
An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Lancet Diabetes and Endocrinology is published by
Elsevier BV
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Lancet Diabetes and Endocrinology publishes reports
-
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Publication History of The Lancet Diabetes and Endocrinology covers
2013 - Present
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Lancet Diabetes and Endocrinology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.
The Lancet Diabetes and Endocrinology Key Factor Analysis
There is no publication fee for submiting manuscript to The Lancet Diabetes and Endocrinology. The Lancet Diabetes and Endocrinology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The language of The Lancet Diabetes and Endocrinology is
-
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The publisher of The Lancet Diabetes and Endocrinology is
Elsevier BV
,
which locates in
Netherlands
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
Cos'è il Fattore di Impatto?
Il fattore di impatto (IF) è spesso utilizzato come indicatore dell'importanza di una rivista nel suo campo. È stato introdotto per la prima volta da Eugene Garfield, il fondatore dell'Istituto per l'informazione scientifica. Sebbene l'IF sia ampiamente utilizzato da istituzioni e medici, le persone hanno un'idea sbagliata diffusa riguardo al metodo di calcolo dell'IF della rivista, al suo significato e al modo in cui può essere utilizzato. L'IF di una rivista non è associata a fattori come la qualità del processo di revisione tra pari e la qualità del contenuto della rivista, ma è una misura che riflette il numero medio di citazioni di articoli pubblicati su riviste, libri, tesi, rapporti di progetto, giornali , atti di conferenze / seminari, documenti pubblicati su Internet, note e qualsiasi altro documento approvato.
Il fattore di impatto è comunemente usato per valutare l'importanza relativa di una rivista nel suo campo e per misurare la frequenza con cui l '"articolo medio" di una rivista è stato citato in un determinato periodo di tempo. La rivista che pubblica più articoli di revisione otterrà IF più elevati. Le riviste con IF più elevate ritenute più importanti di quelle con IF più basse. Secondo Eugene Garfield "l'impatto riflette semplicemente la capacità delle riviste e degli editori di attrarre la migliore carta disponibile". La rivista che pubblica più articoli di revisione otterrà il massimo di IF.
What is Impact Factor?
The impact factor (IF) is frequently used as an indicator of the importance of a journal to its field. It was first introduced by Eugene Garfield, the founder of the Institute for Scientific Information. Although IF is widely used by institutions and clinicians, people have widespread misconception regarding the method for calculating the journal IF, its significance and how it can be utilized. The IF of a journal is not associated to the factors like quality of peer review process and quality of content of the journal, but is a measure that reflects the average number of citations to articles published in journals, books, thesis, project reports, newspapers, conference/seminar proceedings, documents published in internet, notes, and any other approved documents.
Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The The Lancet Diabetes and Endocrinology Fattore di Impatto measures the average number of citations received in a particular year (2020) by papers published in the The Lancet Diabetes and Endocrinology during the two preceding years (2018-2019). Note that 2020 Journal Impact are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of The Lancet Diabetes and Endocrinology.